Back to top

Bausch Health Cos Inc. (BHC)

(Delayed Data from NYSE)

$31.53 USD


-0.29 (-0.91%)

Updated Jun 14, 2021 04:00 PM ET

After-Market: $31.50 -0.03 (-0.10%) 5:48 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy25.41%
5Strong Sell3.06%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth D Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 23% (193 out of 250)

Industry: Medical - Generic Drugs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Trades from $1

Company Summary

Based in Laval, Canada, Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.

The company restructured its business and sold the units that were not performing well.

The company conducts its business in four operating segments:

•    The Bausch + Lomb/International segment consists ...

General Information

Bausch Health Cos Inc.



Phone: 514-744-6792

Fax: 514-744-6272



Industry Medical - Generic Drugs
Sector Medical
Fiscal Year End December
Last Reported Quarter 3/31/2021
Next EPS Date 8/5/2021

EPS Information

Current Quarter EPS Consensus Estimate 0.98
Current Year EPS Consensus Estimate 4.25
Estimated Long-Term EPS Growth Rate 12.70
Next EPS Report Date 8/5/2021

Price and Volume Information

Zacks Rank Premium
Yesterday's Close 31.82
52 Week High 34.80
52 Week Low 14.86
Beta 1.74
20 Day Moving Average 1,971,190.75
Target Price Consensus 35.73


% Price Change
4 Week 9.46
12 Week -3.58
YTD 52.98
% Price Change Relative to S&P 500
4 Week 7.56
12 Week -11.17
YTD 35.28
Share Information
Shares Outstanding (millions) 358.40
Market Capitalization (millions) 11,404.15
Short Ratio 1.00
Last Split Date 10/16/2000
Dividend Information
Dividend Yield 0.00%
Annual Dividend $0.00
Payout Ratio 0.00
Change in Payout Ratio 0.00
Last Dividend Payout / Amount NA / $0.00

Fundamental Ratios

P/E (F1) 7.49
Trailing 12 Months 7.67
PEG Ratio 0.59
EPS Growth
vs. Previous Year 16.85%
vs. Previous Quarter -21.80%
Sales Growth
vs. Previous Year 0.75%
vs. Previous Quarter -8.40%
Price Ratios
Price/Book NA
Price/Cash Flow 3.41
Price / Sales 1.42
3/31/21 352.44
12/31/20 220.03
9/30/20 173.20
3/31/21 4.77
12/31/20 4.53
9/30/20 4.21
Current Ratio
3/31/21 1.10
12/31/20 1.09
9/30/20 1.20
Quick Ratio
3/31/21 0.88
12/31/20 0.86
9/30/20 0.94
Operating Margin
3/31/21 18.43
12/31/20 17.79
9/30/20 16.84
Net Margin
3/31/21 -12.66
12/31/20 -6.98
9/30/20 -23.92
Pre-Tax Margin
3/31/21 -16.75
12/31/20 -11.64
9/30/20 -25.01
Book Value
3/31/21 -0.35
12/31/20 1.70
9/30/20 1.84
Inventory Turnover
3/31/21 1.99
12/31/20 1.93
9/30/20 1.91
3/31/21 NA
12/31/20 39.55
9/30/20 37.16
Debt to Capital
3/31/21 NA
12/31/20 97.53
9/30/20 97.38